Login

†Indicated for prevention & relief of hayfever.¹ 1. Rhinocort Hayfever Approved Product Information January 2009.

We recommend that users click on the Legal Notice before proceeding.

This webpage contains general information only. It is not intended as medical advice and should not be relied upon as such.

Rhinocort Hayfever contains the active ingredient budesonide. Always read the label. Use only as directed.
If symptoms persist see a healthcare professional.

Legal Notice Privacy policy About this site

Rhinocort Hayfever ® is a registered trademark of the AstraZeneca group of companies. Registered user AstraZeneca Pty Limited.

© Copyright 2006 AstraZeneca. All rights reserved.